The European healthcare software investor.
MTIP is a Swiss growth and buyout firm specializing in healthcare software companies. We focus on accelerating European businesses that are transforming global healthcare. Our purpose is to drive growth and improve lives through impactful innovation.
As an impact investor, MTIP focuses on healthcare software companies addressing inequalities. With our MTIP Impact Tracker, we measure and enhance healthcare access and outcomes. By integrating ESG principles and aligning with SDGs, we deliver financial returns and meaningful societal impact.
Healthcare, Private Equity, Healthcare Software, Buyout, Sector Specialist, Growth Equity, and Impact Investing
MTIP is a Swiss growth and buyout firm specializing in healthcare software companies. We scale European businesses with proven market potential, driving meaningful impact for patients, providers, and society at large.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Microsoft IT services, Software Development | Microsoft IT services, Software Development | Other 30 Sep 2024 | | |
HTGF | High-Tech Gründerfonds Venture Capital and Private Equity Principals | HTGF | High-Tech Gründerfonds Venture Capital and Private Equity Principals | Other 30 Jun 2023 | | |
Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 8 May 2023 | | |
Kamet Ventures Venture Capital and Private Equity Principals | Kamet Ventures Venture Capital and Private Equity Principals | Other 19 Sep 2024 | | |
Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 11 Dec 2017 | | |
United Nations Office for Disarmament Affairs International development, International Affairs | United Nations Office for Disarmament Affairs International development, International Affairs | Other 4 Aug 2020 | | |
Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 21 Jan 2021 | |